ResMed (RMD)
(Delayed Data from NYSE)
$203.15 USD
-0.73 (-0.36%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $203.00 -0.15 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RMD 203.15 -0.73(-0.36%)
Will RMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RMD
Here's Why ResMed (RMD) is a Strong Growth Stock
Here's Why ResMed (RMD) is a Strong Growth Stock
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Hold STERIS (STE) Stock Now? Here's What to Consider
Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
Here's Why Staying Invested in Neogen (NEOG) Could be Beneficial
Other News for RMD
How To YieldBoost ResMed To 18.3% Using Options
Orthofix appoints Stephanie Walsh as chief human resources officer
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
10 Health Care Stocks Whale Activity In Today's Session
ResMed cut at Oppenheimer after Eli Lilly’s tirzepatide sleep apnea data